An international research team led by the Research Institute of the McGill University Health Centre (RI MUHC) has made a major genetic breakthrough that could change the way pediatric cancers are treated in the future. Continue reading
Category: News
Study Identifies a New Way Brain Cells Die in Alzheimer’s Disease – Will help lead researchers towards new treatments
A new study challenges conventional thinking about how brain cells die in Alzheimer’s disease. The findings demonstrate a previously unknown mechanism by which the cells die and will help lead researchers in new directions for treating the degenerative brain disease. The study by scientists at the University of Calgary’s Hotchkiss Brain Institute is published this week in the prestigious journal Proceedings of the National Academy of Sciences (PNAS). Continue reading
Defective cell ‘battery’ plays central role in neurodegenerative disease
Jan. 17, 2012 – A devastating neurodegenerative disease that first appears in toddlers just as they are beginning to walk has been traced to defects in mitochondria, the ‘batteries’ or energy-producing power plants of cells. This finding by a team of researchers, led by investigators from the Montreal Neurological Institute and Hospital – The Neuro- at McGill University, was published in this week’s issue of the Proceedings of the National Academy of Sciences of the USA (PNAS). Continue reading
How do we split our attention?
DEC. 21, 2011 – McGill’s Cognitive Neurophysiology Lab team finds that we are natural-born multi-taskers
Imagine you’re a hockey goalie, and two opposing players are breaking in alone on you, passing the puck back and forth. You’re aware of the linesman skating in on your left, but pay him no mind. Your focus is on the puck and the two approaching players. As the action unfolds, how is your brain processing this intense moment of “multi-tasking”? Continue reading
Study finds new way to predict MS diagnosis in children
Early MRI scans can help predict the diagnosis of multiple sclerosis (MS) in children, which may permit earlier initiation of treatment, according to a new national study.
A breakthrough in pinpointing protective mechanisms in Multiple Sclerosis
December 1st, 2011 – In an article published today in the prestigious journal Science, a team of researchers led by Dr Alexander Prat and postgraduate fellow Jorge Alvarez at the University of Montreal Hospital Research Centre (CRCHUM) sheds light on how the blood-brain-barrier (BBB) works to prevent the incursion of the immune system into the brain. Continue reading
Researchers from Université Laval affiliated CHUQ discover a new therapeutic target for Lou Gehrig’s disease
November 14, 2011. – A research team from Université Laval, led by Jean-Pierre Julien, has taken a new step in understanding the cellular mechanisms involved in Lou Gehrig’s disease, also known as amyotrophic lateral sclerosis (ALS). This disease is characterized by degeneration of neurons that control muscle activity. Continue reading
What you want versus how you get it – New neuroeconomics study from The Neuro shows how you make decisions
October 21st – New research reveals how we make decisions. Birds choosing between berry bushes and investors trading stocks are faced with the same fundamental challenge – making optimal choices in an environment featuring varying costs and benefits. Continue reading
Scientists Highlight Link Between Stress and Appetite
Researchers in the Hotchkiss Brain Institute (HBI) at the University of Calgary’s Faculty of Medicine have uncovered a mechanism by which stress increases food drive in rats. This exciting discovery, published in the journal Neuron, could provide important insight into why stress is thought to be one of the underlying contributors to obesity. Continue reading
Potential harm, but no demonstrated benefit from depression screening in primary care
September 19, 2011 – The Canadian Task Force on Preventive Health Care recommends routine screening for depression during primary care visits when systems are available for coordination of assessment and treatment. An article by an international panel of experts, published in the October issue of the Canadian Medical Association Journal, argues that there is no evidence that screening benefits patients and that, moreover, implementation of the practice would further burden an already financially-strapped health care system. Continue reading